Fig. 2.

The clinical characteristics of the non-OLT patients with strong HBsAg-specific T cell interferon-γ response. The clinical characteristics of the non-OLT patients showing strong HBsAg-specific T cell immune responses by enzyme-linked immunospot (ELISPOT) assay are shown. Those patients with stronger HBsAg-specific CD4 T cell IFN-γ response (equal or more than the median; 7 spots) showed lower HBV DNA, lower HBsAg, higher anti-HBs antibody titer, and higher HBcAg-specific immune responses